Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Advocates often highlight the possibility for meaningful therapeutic gains, particularly in diseases where conventional therapies have proven inadequate. However, crucially important to assess the considerable financial burden associated with CPI stem